Up a level |
Number of items: 1.
Dietlein, F., Kalb, B., Jokic, M., Torgovnick, A., Schmitt, A., Buettner, R., Thomas, R. and Reinhardt, H. C. (2015). Combined Chk1-and MK2-inhibition displays robust synergy in KRAS-mutant cancer. Oncol. Res. Treat., 38. S. 169 - 170. BASEL: KARGER. ISSN 2296-5262